Critical – Page 24 – Communicable Diseases Research

Heme oxygenase-1 as an important predictor of the severity of COVID-19

코로나19 중증도의 중요한 예측 인자로서의 헴 옥시게나제-1

Article

Published on 2022-08-242022-09-11
Journal: PLoS ONE [Category] 바이오마커,

Temporal Dynamics of Anti-Type 1 Interferon Autoantibodies in Patients With Coronavirus Disease 2019

코로나바이러스 질병 2019 환자에서 항-유형 1 인터페론 자가항체의 시간적 역학

Article

Published on 2022-08-242022-09-12
Journal: Clinical Infectious Diseases: An Official Publicat [Category] 진단,

The Impact of Prior Infection and Age on Antibody Persistence After Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccine

중증 급성 호흡기 증후군 코로나바이러스 2 메신저 RNA 백신 후 항체 지속성에 대한 이전 감염 및 연령의 영향

Article

Published on 2022-08-242022-09-12
Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 진단,

Facing the Omicron variant-how well do vaccines protect against mild and severe COVID-19? Third interim analysis of a living systematic review

Article

Published on 2022-08-242022-11-16
Journal: Frontiers in Immunology [Category] SARS, 변종,

[키워드] 95% CI acute respiratory syndrome Against approved booster booster dose booster vaccination characterized coronavirus coronavirus disease COVID-19 COVID-19 vaccine Critical death dominant variant Effectiveness estimate European evaluated Evidence Hospitalization ICU admission Immunity immunization indicated Infection interim analysis long-lasting Mild moderate omicron Omicron variant outcomes Participants performed PROTECT ranged receiving remained risk of bia robust SARS-CoV-2 SARS-COV-2 infection searched severe COVID-19 study heterogeneity symptomatic systematic review the SARS-CoV-2 union vaccination Vaccine vaccine effectiveness variant variant of concern website
[DOI] 10.3389/fimmu.2022.940562 PMC 바로가기

Circulating Ubiquitous RNA, A Highly Predictive and Prognostic Biomarker in Hospitalized Coronavirus Disease 2019 (COVID-19) Patients

순환 유비쿼터스 RNA, 입원한 코로나바이러스 질환 2019(COVID-19) 환자의 고도로 예측하고 예후가 좋은 바이오마커

Article

Published on 2022-08-242022-09-11
Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 바이오마커,

[키워드] acute respiratory distress acute respiratory distress syndrome acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 addition Admission Biomarker Biomarkers Blood cell lysis Chain Reaction circulating Clinical management clinical monitoring clinical outcomes Clinical severity coronavirus coronavirus disease Coronavirus disease 2019 correlated COVID-19 COVID-19 patients Critical ddPCR death develop disease severity Diseases evaluate Hospitalized hospitalized COVID-19 hospitalized COVID-19 patient hospitalized COVID-19 patients hospitalized patient Infectious diseases Invasive mechanical ventilation lung cell management marker multi-organ failure organ injury overall survival Patient plasma polymerase chain polymerase chain reaction predict Predictive predictive and prognostic biomarkers prognostic Prognostic biomarkers quantification respiratory respiratory distress Respiratory distress syndrome RNA RNase P RNAseP SARS-CoV-2 SARS-CoV-2 and RNAseP RNAemia severe acute respiratory syndrome Coronavirus severe and critical patients severity significantly survival syndrome tissue injury tissue/cell lysis biomarker. Viral
[DOI] 10.1093/cid/ciab997 PMC 바로가기 [Article Type] Article

Efficacy and Safety of Sarilumab in Hospitalized Patients With Coronavirus Disease 2019: A Randomized Clinical Trial

2019년 코로나바이러스 질환 입원 환자에서 사릴루맙의 효능 및 안전성: 무작위 임상 시험

Randomized Controlled Trial

Published on 2022-08-242022-09-11
Journal: Clinical Infectious Diseases: An Official Publicat [Category] 임상, 진단,

[키워드] 95% CI 95% confidence interval adaptive adults hospitalized Analysis anti-IL-6R monoclonal antibody baseline benefit clinical clinical status coronavirus disease Coronavirus disease 2019 Corticosteroid Corticosteroids corticosteroids) COVID-19 Critical death double-blind Efficacy Efficacy and safety evaluated hazard ratio Hospitalized hospitalized patient hospitalized patients interleukin interleukin-6 interleukin-6 receptor intravenous mechanical ventilation Meta-analysis monoclonal antibodies Patient patients randomized Phase 2 phase 2/3 Phase 3 Placebo placebo-controlled trial Platform trial Post hoc analyses post-hoc analysis primary analysis population Primary outcome proportion Randomized receiving Relative risk risk risk difference Safety sarilumab therapy treated Treatment Trial with COVID-19
[DOI] 10.1093/cid/ciac153 PMC 바로가기 [Article Type] Randomized Controlled Trial

Inactivated vaccine injection and immunoglobulin G levels related to severe coronavirus disease 2019 (Delta) pneumonia in Xi’an, China: A single-centered, retrospective, observational study

Article

Published on 2022-08-232022-11-15
Journal: Frontiers in Cellular and Infection Microbiology [Category] SARS, 변종, 진단,

[키워드] acute respiratory syndrome analyzed B.1.617.2 booster booster shot Chinese coronavirus coronavirus disease COVID-19 COVID-19 severity Critical death Delta delta variant effective Efficacy Epidemic evaluate Hospitalization IgG antibody IgG level immune response Immunoglobulin Immunoglobulin G Inactivated vaccine Infection infections injection International logistic regressions men Mild moderate Older Patient patients with COVID-19 Pneumonia PROTECT protective effect public health emergency retrospective Retrospective study risk severe cases severe coronavirus disease severity underlying diseases Vaccine vaccine injection World Health Organization
[DOI] 10.3389/fcimb.2022.933100 PMC 바로가기

Comparison between the persistence of post COVID-19 symptoms on critical patients requiring invasive mechanical ventilation and non-critical patients

Observational Study

Published on 2022-08-222022-10-04
Journal: PLoS ONE [Category] SARS, 임상,

[키워드] addition adjusted affected association Asymptomatic Care Cognitive impairment collected complications coronavirus disease COVID-19 COVID-19 pandemic COVID-19 patient COVID-19 symptom Critical develop discharged Dyspnea eligible patient evaluate fatigue Follow-up headache Health Assessment hospital Hospital stay Hospitalization ICU IMV intubation Invasive mechanical ventilation median age men multisystemic Multivariate analysis Musculoskeletal musculoskeletal symptom Neuropsychiatric participant Patient patients performed persistence physician predominant proportion Psychological questionnaire reported required Respiratory disease severe COVID-19 disease significant difference Symptom Symptoms syndrome
[DOI] 10.1371/journal.pone.0273041 PMC 바로가기 [Article Type] Observational Study

Novel insight on marker genes and pathogenic peripheral neutrophil subtypes in acute pancreatitis

Article

Published on 2022-08-222022-11-15
Journal: Frontiers in Immunology [Category] 바이오마커, 유전자 메커니즘,

Real-World Evidence for COVID-19 Delta Variant’s Effects on the Digestive System and Protection of Inactivated Vaccines from a Medical Center in Yangzhou, China: A Retrospective Observational Study

Observational Study

Published on 2022-08-192022-10-04
Journal: International journal of clinical practice [Category] SARS, 바이오마커, 변종, 임상,

[키워드] addition Affect alanine aminotransferase ALT analysis of variance ANOVA AST Bilirubin biochemical center changes in Chinese Cohort Coronavirus disease 2019 COVID-19 Critical Critical disease Delta delta variant diagnosed digestive system dysfunction early stage Effect evaluate function Gastrointestinal symptom global public health IL-6 level Inactivated vaccine inactive Infection interleukin 6 (IL-6 investigated lactate dehydrogenase LDH liver dysfunction marker mild illness moderate no significant difference p value Patient prevalent Prevent promoted PROTECT protection public health reported respiratory tract retrospective serum severity Significant significant difference significantly more Sinopharm Sinovac statistically significant Symptom System three group three groups total bilirubin Treatment Vaccine variant was used
[DOI] 10.1155/2022/7405448 PMC 바로가기 [Article Type] Observational Study